Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

Expanded access is currently available for this treatment.

Study NCT00338442 Information provided by Cangene Corporation

First Received: June 15, 2006 Last Updated: November 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	Expanded access is currently available for this treatment.
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)